ANTI-STREPTOLYSIN O (QUANTITATIVE)

Primary DI

06975225461803

Basic UDI-DI Code

B-06975225461803

Reference

DTSH090110

Device Types

None provided

Regulation

Eu Ivdd

Classification

Eu Ivd General

Status

On The Market

Manufacturer

Da Te Bioengineering Technology Co., LTD.

This kit is intended for in vitro quantitative detection of anti-streptolysin O (ASO) in human serum. After the body was streptococcal infection can produce anti-streptolysin O antibody, the antibody is streptococcal exotoxin. ASO detection can help diagnose the cause of hemolytic streptococcus diseases such as rheumatoid, acute renal disease, scarlet fever and tonsillitis and other diseases. Rheumatic fever, acute glomerulonephritis, erythema nodosum, scarlet fever, acute tonsillitis and so on ASO increased significantly. Minority hepatitis, connective tissue disease, tuberculosis and multiple myeloma patients can make fibromatosis ASO increased. Apart from the acute phase serum of patients with rheumatoid arthritis is usually not detected elevated ASO values. Nephrotic syndrome and antibody deficiency of serum only very low levels of ASO syndrome.

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).